About P2 Science
P2 Science is a company based in Woodbridge (United States) founded in 2011 by Patrick Foley and Paul Anastas. P2 Science has raised $62.16 million across 10 funding rounds from investors including Chanel, BASF and Elm Street Ventures. P2 Science offers products and services including Citropol® Series, PIOz™, and PICE™. P2 Science operates in a competitive market with competitors including LanzaTech, Evonik, Again, Manus Bio and Proklean Technologies, among others.
- Headquarter Woodbridge, United States
- Founders Patrick Foley, Paul Anastas
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name P2 Holding Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$62.16 M (USD)
in 10 rounds
-
Latest Funding Round
$23 M (USD), Series D
May 27, 2026
-
Investors
Chanel
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of P2 Science
P2 Science offers a comprehensive portfolio of products and services, including Citropol® Series, PIOz™, and PICE™.
Sustainable polymers derived from pine oils for haircare and skincare uses.
Technology converting plant oils into intermediates for fragrances and crops.
Terpene conversion method for creating aroma materials in perfumery.
People of P2 Science
Unlock access to complete
Unlock access to complete
Funding Insights of P2 Science
P2 Science has successfully raised a total of $62.16M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in P2 Science
P2 Science has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include Chanel, BASF and Elm Street Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward agriculture and food sectors.
|
Locked | Locked | Locked | |
|
VC firm investing in seed & early stage companies in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for P2 Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by P2 Science
Investment portfolio details for P2 Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - P2 Science
Detailed financials for P2 Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
P2 Science Comparisons
Peer comparison for P2 Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of P2 Science
P2 Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LanzaTech, Evonik, Again, Manus Bio and Proklean Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Waste carbon is treated via a bio-processing platform.
|
|
| Locked | Locked | Locked |
Green specialty chemicals are developed and supplied for multiple industries.
|
|
| Locked | Locked | Locked |
Chemicals and fertilizers are produced from industrial CO2 waste.
|
|
| Locked | Locked | Locked |
Phytochemicals are developed using microbial fermentation processes.
|
|
| Locked | Locked | Locked |
Probiotic-based cleaning agents are manufactured for industrial use.
|
|
| Locked | Locked | Locked |
Green chemicals are developed using microcapsule technology for sustainability.
|
Detailed competitors of P2 Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on P2 Science
Complete news archive for P2 Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about P2 Science
P2 Science was founded in 2011.
P2 Science is headquartered in Woodbridge, United States.
Oihana Elizalde is the current CEO of P2 Science.
P2 Science is a funded company, having raised a total of $62.16M across 10 funding rounds to date.
Founded in 2011 and based in Woodbridge, United States, P2 Science operates in the green chemicals sector. Bio-renewable speciality chemicals are developed and produced for applications in cosmetics, personal care, flavours, fragrances, renewable polymers, and bioactive compounds. Petroleum-like biopolymers are created from sustainable resources, supporting diversified product portfolios in the speciality chemicals industry.
P2 Science's top competitors include Manus Bio, LanzaTech and Mint Innovation.
P2 Science offers Citropol® Series, PIOz™, and PICE™.
P2 Science has 17 investors. Key investors include Chanel, BASF, Elm Street Ventures, Lewis & Clark Agrifood, and Safer Made.